Sze Ting Lee

Sze Ting Lee

UNVERIFIED PROFILE

Are you Sze Ting Lee?   Register this Author

Register author
Sze Ting Lee

Sze Ting Lee

Publications by authors named "Sze Ting Lee"

Are you Sze Ting Lee?   Register this Author

41Publications

857Reads

17Profile Views

Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse.

Eur J Nucl Med Mol Imaging 2020 Feb 5. Epub 2020 Feb 5.

Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-020-04706-0DOI Listing
February 2020

Novel Target Selection for Nuclear Medicine Studies.

Semin Nucl Med 2019 09 6;49(5):357-368. Epub 2019 Jul 6.

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia; Faculty of Medicine, The University of Melbourne, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2019.06.004DOI Listing
September 2019

F-FDG Metabolic Tumor Volume: Association with Short- and Long-Term Feeding Tube Use in Head and Neck IMRT.

Dysphagia 2019 06 28;34(3):341-349. Epub 2018 Sep 28.

Department of Radiation Oncology, Olivia Newton John Cancer Wellness & Research Centre, Austin Health, Heidelberg, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00455-018-9946-zDOI Listing
June 2019

Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications.

Int J Radiat Oncol Biol Phys 2018 11 21;102(4):783-791. Epub 2018 Mar 21.

Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia; School of Cancer Medicine, Latrobe University, Melbourne, Victoria, Australia; Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183054
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.03.013DOI Listing
November 2018

Metastatic clear cell renal cell carcinoma demonstrating intense uptake on Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature.

World J Nucl Med 2018 Jul-Sep;17(3):195-197

Department of Molecular Imaging and Therapy, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/wjnm.WJNM_38_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034548PMC
July 2018

Nuclear medicine in the era of personalised medicine.

Intern Med J 2018 05;48(5):497-499

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13789DOI Listing
May 2018

Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.

ANZ J Surg 2018 Mar 24;88(3):E108-E113. Epub 2016 Jul 24.

Department of Surgery, Austin Hospital, The University of Melbourne, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.13680DOI Listing
March 2018

Receptor Occupancy Imaging Studies in Oncology Drug Development.

AAPS J 2018 03 8;20(2):43. Epub 2018 Mar 8.

Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-018-0203-zDOI Listing
March 2018

Theranostics of Neuroendocrine Tumors.

Visc Med 2017 Oct 20;33(5):358-366. Epub 2017 Oct 20.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/480383
Publisher Site
http://dx.doi.org/10.1159/000480383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697502PMC
October 2017

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET.

Asia Ocean J Nucl Med Biol 2014 ;2(1):3-11

Centre for PET, Austin Hospital, Heidelberg, Victoria, Australia; Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia; Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937709PMC
July 2016

Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.

J Nucl Med 2016 06 3;57(6):974-80. Epub 2016 Mar 3.

Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia Department of Medical Oncology, Austin Health, Heidelberg, Melbourne, Australia Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.169839DOI Listing
June 2016

The Current Role of PET/CT in Radiotherapy Planning.

Curr Radiopharm 2015 ;8(1):38-44

Department of Molecular Imaging and Therapy, Austin Health Level 1, Harold Stokes Building, Studley Road, Heidelberg, VIC, 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874471008666150316222618DOI Listing
February 2016

Scientific basis of personalised tomographic radiation planning for radioembolisation: A form of brachytherapy planning.

J Med Imaging Radiat Oncol 2015 Oct 4;59(5):617-8. Epub 2015 Aug 4.

Department of Radiology, Department of Molecular Imaging and Therapy, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/1754-9485.12346
Publisher Site
http://dx.doi.org/10.1111/1754-9485.12346DOI Listing
October 2015

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

J Clin Oncol 2015 Aug 29;33(24):2609-16. Epub 2015 Jun 29.

Marika Ciprotti, Niall C. Tebbutt, Fook-Thean Lee, Sze-Ting Lee, Hui K. Gan, Wendie Hopkins, Fiona E. Scott, Andrew M. Scott, Ludwig Institute for Cancer Research; David C. McKee, Graeme J. O'Keefe, Sylvia J. Gong, Geoffrey Chong, Bridget Chappell, Andrew M. Scott, Austin Health, Melbourne, Australia; Martin W. Brechbiel, National Cancer Institute, Bethesda, MD; Archie N. Tse, Jonathan Greenberg, Daiichi Sankyo Co., Ltd, Parsippany, NJ; Mendel Jansen, Daiichi Sankyo Development Ltd, Gerrards Cross, Buckinghamshire, United Kingdom; Manabu Matsumura, Masakatsu Kotsuma, Rira Watanabe, Daiichi Sankyo Co., Ltd, Tokyo, Japan; Robert A. Beckman, Georgetown University Medical Center and Ralph Venhaus, Ludwig Institute for Cancer Research, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.60.4256
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.60.4256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881374PMC
August 2015

Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.

Int J Radiat Oncol Biol Phys 2015 Jun 8;92(2):438-45. Epub 2015 Apr 8.

Radiation Oncology Centre, Austin Health, Victoria, Australia; University of Melbourne, Victoria, Australia; Royal Marsden Hospital, National Health Service Foundation Trust, London, United Kingdom; Department of Medical Imaging and Radiation Sciences, Monash University, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.02.004DOI Listing
June 2015

Current role of PET, CT, MR for invasive bladder cancer.

Curr Urol Rep 2013 Apr;14(2):84-9

Ludwig Institute for Cancer Research, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-013-0308-yDOI Listing
April 2013

Periarticular FDG Uptake on PET/CT in malignant melanoma-metastatic or misleading?

Ann Acad Med Singapore 2013 Mar;42(3):159-60

Centre for PET, Austin Health, Heidelberg, Australia.

View Article

Download full-text PDF

Source
March 2013

Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases.

J Nucl Med 2012 Sep 13;53(9):1345-51. Epub 2012 Jul 13.

Department of Surgery, Austin Hospital, University of Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.112.102749DOI Listing
September 2012

Impact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer.

ANZ J Surg 2012 Jan-Feb;82(1-2):30-5. Epub 2011 Jan 7.

Department of Surgery, University of Melbourne, Austin Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1445-2197.2010.05601.xDOI Listing
August 2012

PET in prostate and bladder tumors.

Semin Nucl Med 2012 Jul;42(4):231-46

Centre for PET, Austin Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2012.03.002DOI Listing
July 2012

F-18 FDG uptake in hemorrhoids in a patient with diffuse large B-cell lymphoma.

Clin Nucl Med 2012 Jan;37(1):91-2

Division of Nuclear Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e3182336004DOI Listing
January 2012

Are we ready for dual-time point FDG PET imaging?

J Med Imaging Radiat Oncol 2011 Aug;55(4):351-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1754-9485.2011.02296.xDOI Listing
August 2011

Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.

J Med Imaging Radiat Oncol 2011 Jun;55(3):320-32

Austin Health Radiation Oncology Centre, Heidelberg West Centre for PET Ludwig Institute for Cancer Research Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1754-9485.2011.02274.xDOI Listing
June 2011

Benign ectopic multinodular thyroid tissue in the submandibular region with a coexistent normotopic multinodular thyroid gland harboring papillary thyroid cancer.

Clin Nucl Med 2010 Aug;35(8):618-9

Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e3181e4df8bDOI Listing
August 2010

Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.

Prostate 2009 Jan;69(1):92-104

Tumour Targeting Laboratory, Ludwig Institute for Cancer Research, Melbourne Centre for ClinicalSciences, Austin Hospital, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597150PMC
January 2009

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.

Semin Nucl Med 2007 Nov;37(6):451-61

Centre for PET, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2007.07.001DOI Listing
November 2007